11 results
Sepsis Treatment Overview #Management #EM #IM #PCC #Sepsis #Overview #BMJ
Sepsis Treatment ... Overview #Management ... #EM #IM #PCC #Sepsis ... #Overview #BMJ
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Lung Abscess - Clinical ... Management: • ... Clindamycin in case of PCN ... Cavitation > 6 cm
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
Paraneoplastic effects of SCC ... - Autoimmune: thyroid ... Differential DX: - Thyroid ... Miller Fischer and PCB ... Gravis #diagnosis #management
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... Catheters (CVL/PICC ... within one week to assess ... or TEE unless clinical ... #candidiasis #treatment
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... GrepMed Handbook Clinical ... Acute Diarrhea (>3 BM ... non-toxigenic • Stool PCR ... equivocal • CT A/P: Assess
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Diagnosis and Management ... Antibiotics (Bactrim, PCN ... Workup: • Assess ... PEA/VF • Labs: BMP ... (Assess GFR), ±
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
should be based on clinical ... Antimicrobial treatment ... tuberculomas, or abscesses ... • JC-virus PCR ... - Generally >3 cm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Assess functional ... event, follow ACC ... Change in clinical ... Cataract Plan for Meds ... medical and surgical management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
emboli • Lung abscess ... characteristic features Clinical ... staining, NAA (PCR ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
emboli • Lung abscess ... characteristic features Clinical ... staining, NAA (PCR ... TB #Diagnosis #Management ... #Treatment #ActiveTB